Swedish registers to examine drug safety and clinical issues in RA.
Data from several different monitoring systems are examined. The potential for registers based on data obtained from clinical practice, and linkage of such data to national health and population registers, is discussed. The approach described is a possible prototype for long term surveillance systems needed for the safe introduction of new treatments.
Askling
J
J
Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden. johan.askling@ki.se
Fored
C M
CM
Geborek
P
P
Jacobsson
L T H
LT
van Vollenhoven
R
R
Feltelius
N
N
Lindblad
S
S
Klareskog
L
L
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004992:Ethics, Medical; D005500:Follow-Up Studies; D006801:Humans; D008498:Medical Record Linkage; D012042:Registries; D012449:Safety; D013548:Sweden; D016896:Treatment Outcome
D018501:Antirheumatic Agents